FULGENT PHARMA
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97822517
- Registration number
- 7995377
- Mark type
- Stylized text
- Filed
- 03 Mar 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 21 Oct 2025
- Attorney of record
- April L. Besl
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs; medicinal preparations for treating cancer, namely, nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs
- Class 042 — Scientific and technological services: Medical research in the field of oncology; clinical research in the field of oncology; pharmaceutical research and development in the field of oncology; research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; medical research, namely, research of nanoencapsulated chemotherapy drugs, targeted therapies for leukemia, and small-molecule-based immuno-oncology drugs
Owner
- Fulgent Genetics, Inc., El Monte, CA, US
- Fulgent Genetics, Inc., El Monte, CA, US
- Fulgent Genetics, Inc., Temple City, CA, US
Prior registrations
Prosecution history
- 12 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Sept 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 01 May 2025 — USE AMENDMENT FILED
- 27 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jun 2025 — ASSIGNED TO EXAMINER
- 04 Jun 2025 — ASSIGNED TO EXAMINER